Bavarian Nordic says more upgrades could be on the way
The biotech firm’s third upgrade in three weeks came hot on the heels of a recent contract with the US government. Should more orders follow, it could result in more upgrades, says Bavarian’s head of investor relations.
by marketwire, translated by daniel pedersen
Bavarian Nordic raised its expectations for the full year on Friday last week, a consequence of the vaccine firm signing a contract with the US government concerning half a million doses of monkeypox vaccine Jynneos.